FFCP PHASE1:Mm9::chr16:85153021..85153039,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=6 | |MCL_coexpression_id=6 | ||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr16:85153021..85153039,+ | |||
|description=CAGE_peak_at_chr16:85153021..85153039,+ | |description=CAGE_peak_at_chr16:85153021..85153039,+ | ||
|id=chr16:85153021..85153039,+ | |id=chr16:85153021..85153039,+ | ||
|ontology_enrichment_celltype=CL:0000355!3.30e-15!9 | |ontology_enrichment_celltype=CL:0000355!3.30e-15!9 | ||
|ontology_enrichment_celltype_v019_2=CL:0000355,3.30e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!8.97e-44!3;DOID:4045!8.97e-44!3;DOID:0050686!2.23e-22!6 | |ontology_enrichment_disease=DOID:0060100!8.97e-44!3;DOID:4045!8.97e-44!3;DOID:0050686!2.23e-22!6 | ||
|ontology_enrichment_disease_v019_2=DOID:0060100,8.97e-44,3;DOID:4045,8.97e-44,3;DOID:0050686,2.23e-22,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!3.30e-15!9;UBERON:0002036!3.30e-15!9;UBERON:0002385!3.30e-15!9;UBERON:0000486!3.30e-15!9;UBERON:0001015!3.30e-15!9;UBERON:0004290!3.30e-15!9;UBERON:0003082!3.30e-15!9;UBERON:0000383!9.08e-14!10;UBERON:0002329!1.37e-12!11;UBERON:0003077!1.37e-12!11;UBERON:0003059!1.37e-12!11;UBERON:0007282!1.37e-12!11;UBERON:0009618!1.37e-12!11;UBERON:0007285!1.37e-12!11;UBERON:0000914!2.10e-08!17 | |ontology_enrichment_uberon=UBERON:0001134!3.30e-15!9;UBERON:0002036!3.30e-15!9;UBERON:0002385!3.30e-15!9;UBERON:0000486!3.30e-15!9;UBERON:0001015!3.30e-15!9;UBERON:0004290!3.30e-15!9;UBERON:0003082!3.30e-15!9;UBERON:0000383!9.08e-14!10;UBERON:0002329!1.37e-12!11;UBERON:0003077!1.37e-12!11;UBERON:0003059!1.37e-12!11;UBERON:0007282!1.37e-12!11;UBERON:0009618!1.37e-12!11;UBERON:0007285!1.37e-12!11;UBERON:0000914!2.10e-08!17 | ||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.30e-15,9;UBERON:0002036,3.30e-15,9;UBERON:0002385,3.30e-15,9;UBERON:0000486,3.30e-15,9;UBERON:0007503,3.30e-15,9;UBERON:0001015,3.30e-15,9;UBERON:0002329,3.30e-15,9;UBERON:0003082,3.30e-15,9;UBERON:0003059,3.30e-15,9;UBERON:0007282,3.30e-15,9;UBERON:0004290,3.30e-15,9;UBERON:0009618,3.30e-15,9;UBERON:0000383,9.08e-14,10;UBERON:0007524,1.37e-12,11;UBERON:0003077,1.37e-12,11;UBERON:0007285,1.37e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.4856703372656,10.9386948233332,8.37637990358077,64.7054636834116,18.442228093878,7.2826552954673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,15.4856703372656,10.9386948233332,8.37637990358077,64.7054636834116,18.442228093878,7.2826552954673,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr16:85153021..85153039,+ | |short_description=p@chr16:85153021..85153039,+ | ||
}} | }} |
Latest revision as of 03:10, 4 August 2015
Short description: | p@chr16:85153021..85153039, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr16:85153021..85153039, + |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 3.30e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 3.30e-15 | 9 |
striated muscle tissue | 3.30e-15 | 9 |
muscle tissue | 3.30e-15 | 9 |
multilaminar epithelium | 3.30e-15 | 9 |
epithelial vesicle | 3.30e-15 | 9 |
musculature | 3.30e-15 | 9 |
somite | 3.30e-15 | 9 |
myotome | 3.30e-15 | 9 |
presomitic mesoderm | 3.30e-15 | 9 |
presumptive segmental plate | 3.30e-15 | 9 |
dermomyotome | 3.30e-15 | 9 |
trunk paraxial mesoderm | 3.30e-15 | 9 |
musculature of body | 9.08e-14 | 10 |
dense mesenchyme tissue | 1.37e-12 | 11 |
paraxial mesoderm | 1.37e-12 | 11 |
presumptive paraxial mesoderm | 1.37e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 8.97e-44 | 3 |
muscle cancer | 8.97e-44 | 3 |
organ system cancer | 2.23e-22 | 6 |